Abstract
Objective: Mental health care providers are in a unique position to detect, prevent, and offer brief interventions for adolescents with substance use problems. While substance use and mental health disorders commonly co-occur, few pediatric mental health professionals possess the necessary training to identify and treat substance use issues. The goal of this paper is to provide guidance for mental health professionals working with adolescents on how to detect, intervene, and refer adolescents for substance use treatment.
Method: A series of clinical case examples and vignettes provide scenarios for helping educate providers in screening for substance use, preventing/delaying substance use initiation, delivering brief early interventions, and motivating adolescents for specialized substance use treatment when necessary.
Conclusions: The importance of discussing substance use with each adolescent, being attuned to common warning signs of substance use, taking caution in prescribing medications with abuse potential, importance of family involvement, and use of motivational interviewing techniques are discussed.
Keywords: adolescents, guidelines, health care providers, prevention, screening, substance use, treatment.
Adolescent Psychiatry
Title:Clinical Guidelines for the Detection, Prevention, and Early Intervention of Adolescent Substance Use
Volume: 3 Issue: 2
Author(s): Viktoriya Magid and Regan Settles
Affiliation:
Keywords: adolescents, guidelines, health care providers, prevention, screening, substance use, treatment.
Abstract: Objective: Mental health care providers are in a unique position to detect, prevent, and offer brief interventions for adolescents with substance use problems. While substance use and mental health disorders commonly co-occur, few pediatric mental health professionals possess the necessary training to identify and treat substance use issues. The goal of this paper is to provide guidance for mental health professionals working with adolescents on how to detect, intervene, and refer adolescents for substance use treatment.
Method: A series of clinical case examples and vignettes provide scenarios for helping educate providers in screening for substance use, preventing/delaying substance use initiation, delivering brief early interventions, and motivating adolescents for specialized substance use treatment when necessary.
Conclusions: The importance of discussing substance use with each adolescent, being attuned to common warning signs of substance use, taking caution in prescribing medications with abuse potential, importance of family involvement, and use of motivational interviewing techniques are discussed.
Export Options
About this article
Cite this article as:
Magid Viktoriya and Settles Regan, Clinical Guidelines for the Detection, Prevention, and Early Intervention of Adolescent Substance Use, Adolescent Psychiatry 2013; 3 (2) . https://dx.doi.org/10.2174/2210676611303020012
DOI https://dx.doi.org/10.2174/2210676611303020012 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome
CNS & Neurological Disorders - Drug Targets The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View
Current Alzheimer Research Fibromyalgia: Mechanisms, Current Treatment and Animal Models
Current Pharmaceutical Biotechnology A Highly Polar Phytocomplex Involving Rutin is Responsible for the Neuromuscular Facilitation Caused by Casearia sylvestris (guaçatonga)
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: Current Updates on Association Between Alzheimer’s Disease and Type 2 Diabetes Mellitus - Volume II)
CNS & Neurological Disorders - Drug Targets Tissue Doppler Imaging: Beautiful Noise
Current Cardiology Reviews An Overview of Recent Patents on Oral Osmotic Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Lithium and Kidney, 60 Years Later
Current Drug Safety Molecular Mechanisms in Aging and Current Strategies to Counteract Sarcopenia
Current Aging Science NLRP3 Is Involved in Ischemia/Reperfusion Injury
CNS & Neurological Disorders - Drug Targets Exercise for the Overweight and Obese
Current Pharmaceutical Design Nitric Oxide and Dopamine Neurons. Implications for Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Mini-Reviews in Medicinal Chemistry State of the Art: Psychotherapeutic Interventions Targeting the Psychological Factors Involved in IBD
Current Drug Targets Metabolic Fate of Endocannabinoids
Current Neuropharmacology MicroRNA-130b Promotes Wear Particle-Induced Osteolysis via Downregulating Frizzled-Related Protein (FRZB)
Current Neurovascular Research Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Current Neurovascular Research Enzymatic Activity and Protein Interactions in Alpha/Beta Hydrolase Fold Proteins: Moonlighting Versus Promiscuity
Protein & Peptide Letters Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Current Neuropharmacology Paradigm Shifts in our Views on Inclusion Bodies
Current Biochemical Engineering (Discontinued)